|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||66.76 - 67.65|
|52 Week Range||54.91 - 85.92|
|PE Ratio (TTM)||90.36|
|Earnings Date||Apr 24, 2018 - Apr 30, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||78.90|
Oncology is leading the precision medicine revolution, as clinical researchers leverage and identify biomarkers to target patient subsets with more effective treatments, and the promise of improving Phase I success rate probability by three times 1.
Stock Monitor: Medical Transcription Billing Post Earnings Reporting LONDON, UK / ACCESSWIRE / March 15, 2018 / Active-Investors.com has just released a free earnings report on Medidata Solutions, Inc. ...
Medidata today announced that Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, February 28, 2018, at 11:15 a.m.
Santen Pharmaceutical Co., Ltd, is expanding its use of the Medidata Clinical Cloud® with the adoption of Edge CTMS to support its clinical trial operations, in ophthalmology, across Japan, Asia, USA and the EU.
Medidata today announced that eClinical Solutions LLC, an industry-leading provider of end-to-end data management services and cloud based products for clinical data optimization, is expanding their technology partnership to further improve clinical trial processes and help life sciences researchers deliver innovative therapies to patients with the adoption of Rave Imaging.
Medidata has been named to Barron’s first annual list of the “100 Most Sustainable Companies” in the U.S., demonstrating the company's positive impact in five categories: shareholders, employees, customers, community and planet.
Aperio, a leading clinical research organization formerly known as iNNO Clinical Outcomes, has expanded its use of the Medidata Clinical Cloud ® platform to include Edge eTMF and Edge CTMS, Medidata announced today.
As clinical trials become more complex, sponsors and contract research organizations are looking for a unified platform to help them overcome challenges such as dealing with disparate systems, complying with new regulatory requirements and managing an increasing variety and volume of data.
NEW YORK, Feb. 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Penske ...
Medidata Solutions , is pleased to announce the 13th annual NEXT Conference series will commence in Europe in March 2018, with events in Basel , Frankfurt and London .
Medidata Solutions Inc (NASDAQ:MDSO) trades with a trailing P/E of 90.1x, which is higher than the industry average of 44.6x. While this makes MDSO appear like a stock to avoidRead More...
The New York-based company said it had profit of 23 cents per share. Earnings, adjusted for one-time gains and costs, came to 41 cents per share. The results surpassed Wall Street expectations. The average ...
Medidata announced today that its virtual trials platform, Engage, is now being offered as a part of the Medidata Clinical Cloud®, providing researchers unmatched flexibility to conduct clinical trials virtually, on-site, or as a hybrid.
Medidata today announced its financial results for the fourth quarter and full year 2017 and provided detailed financial guidance for the full year 2018.
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Medidata Solutions, Inc. (NASDAQ: MDSO ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 8, 2018 at 8:00 AM Eastern ...
Targeted therapies create new opportunities for patients, but can require complex trial design to achieve their promise. These studies highlight the importance of working with the best clinical trial sites, and managing enrollment and key operational performance indicators in clinical development.
Partnership will democratize access to clinical trials and help community health systems find and enroll eligible patients at unprecedented scale NEW YORK and SAN FRANCISCO , Jan. 31, 2018 /PRNewswire/ ...
Medidata , the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership to transform oncology clinical trials for the age of precision medicine.
Medidata , the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its fourth quarter 2017 financial results before the open of the market on Thursday, February 8, 2018.
Qlik®, a leader in data analytics, today announced that its board appointed Mike Capone, former COO of Medidata Solutions , as Qlik’s new CEO. Capone brings a valuable combination of customer perspective, operational expertise, and market focus to Qlik.
Medidata , the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the Medical Research Collaborating Center , one of the leading research centers of biomedical science in South Korea, has selected Medidata Rave® to accelerate the overall regulatory data submission process during clinical trials.
Medidata , the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann, chief financial officer, will present at the J.P.